Eye Drops for Red Eyes: LUMIFY significantly reduces redness to help reveal your eyes' natural radiance. From the eye care experts at Bausch and Lomb, LUMIFY works in 1 minute and lasts up to 8 ...

This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just filed cases in state and federal courts.

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

This is not the way to make your brown eyes blue. If you’ve been eyeing those supposed eye color-changing eye drops being pushed on TikTok and other social media platforms, beware. Such drops ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes.

The stock is surging today on news the company is considering selling itself. Of note, Bausch + Lomb is the eye-care subsidiary of Bausch Health Companies, which was formerly known as Valeant ...

Bausch+Lomb ($BLCO), a contact lens supplier, is exploring a sale to address concerns raised by its lenders like Apollo ...

Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a market cap of $6.27 billion on Monday.

Bausch + Lomb’s chief executive Brent Saunders is a well-known dealmaker who oversaw Allergan’s $63bn sale to AbbVie. Bausch Health retained an 88 per cent shareholding in the eye care ...

Titus Welliver, the man behind the iconic Harry Bosch, recently provided some tantalizing details about the upcoming Bosch ...

Bausch + Lomb has a pretty solid balance sheet that hasn’t changed a lot in the last few quarters. Read why I remain bullish ...